Form D · Biotechnology

GelMEDIX, Inc.

Cambridge, MA · CIK 0001815624

Offering snapshot reported Apr 30, 2026 · SEC filing

Reported sold
$747K
Offering amount: $2.5M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 1, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$374K$747KOct 14, 2025: $397,000.00Oct 14, 2025Jan 8, 2026: $542,000.00Jan 8, 2026Apr 30, 2026: $747,000.00Apr 30, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$542,000 → $747,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 30, 2026Amendment$747,000$205,000vs Jan 8, 20265SEC filing
Jan 8, 2026Amendment$542,000$145,000vs Oct 14, 20255SEC filing
Oct 14, 2025Initial$397,000No comparison2SEC filing
Feb 4, 2025Initial$1,000,000No comparison2SEC filing
Mar 26, 2024Initial$1,893,339No comparison17SEC filing
Aug 10, 2022Amendment$6,440,000$3,840,000vs Apr 29, 20214SEC filing
Apr 29, 2021Amendment$2,600,000$2,350,000vs Jun 19, 20204SEC filing
Jun 19, 2020Initial$250,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-560746

Source: Form D, filed Apr 30, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nasim Annabi Director
Jeffrey Behrens Director, Executive
Michael Cima Director
Max Cotler Director, Executive
Reza Dana Director
Arthur Driscoll Director, Executive
Parinaz Motamedy Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
238 Main Street, Fifth Floor
Cambridge, MA, 02142